IL1A and metabolic dysfunction-associated steatotic liver disease: This aligns with the observation of Abdel-Hamed et al. [20], who reported in NAFLD patients a positive correlation between serum miR122 and serum levels of IL-1α (Figure 3), an inflammatory cytokine.